全文获取类型
收费全文 | 218篇 |
免费 | 32篇 |
专业分类
儿科学 | 11篇 |
妇产科学 | 1篇 |
基础医学 | 31篇 |
临床医学 | 15篇 |
内科学 | 104篇 |
皮肤病学 | 4篇 |
神经病学 | 8篇 |
外科学 | 54篇 |
综合类 | 5篇 |
预防医学 | 10篇 |
眼科学 | 1篇 |
药学 | 2篇 |
中国医学 | 1篇 |
肿瘤学 | 3篇 |
出版年
2023年 | 1篇 |
2022年 | 5篇 |
2021年 | 11篇 |
2020年 | 6篇 |
2019年 | 6篇 |
2018年 | 12篇 |
2017年 | 5篇 |
2016年 | 13篇 |
2015年 | 11篇 |
2014年 | 9篇 |
2013年 | 13篇 |
2012年 | 19篇 |
2011年 | 34篇 |
2010年 | 18篇 |
2009年 | 10篇 |
2008年 | 15篇 |
2007年 | 6篇 |
2006年 | 13篇 |
2005年 | 3篇 |
2004年 | 7篇 |
2003年 | 6篇 |
2002年 | 4篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1980年 | 2篇 |
1940年 | 1篇 |
1936年 | 1篇 |
1933年 | 1篇 |
排序方式: 共有250条查询结果,搜索用时 765 毫秒
31.
32.
Zhang Y Chaisson CE McAlindon T Woods R Hunter DJ Niu J Neogi T Felson DT 《Journal of clinical epidemiology》2007,60(1):50-55
OBJECTIVES: To evaluate the feasibility of conducting an online case-crossover study of triggers for recurrent disease flares. METHODS: We conducted an online case-crossover study of triggers for recurrent flares using gout as a paradigm. We constructed a Web site and recruited individuals with history of gout via the Internet. We confirmed gout diagnosis by reviewing each subject's medical records. We collected via the Internet exposure information during the intercritical period using a scheduled Control-period Questionnaire, and prior to recurrent gout attacks using a Hazard-period Questionnaire. RESULTS: Over 10 months we recruited 197 subjects with a history of gout from 41 states and the District of Columbia. We obtained medical records from 172 subjects. All participants had experienced at least one recurrent attack and filled out required questionnaires. The median time between the date of an attack and the date of logging on to the Web site was 2 days. The incidence rate of recurrent gout attacks was 1.03 per person-year. Longer disease duration and presence of comorbidities appeared to increase the risk of recurrent flares. CONCLUSION: The results of this study demonstrate that a case-crossover study can be successfully conducted through the Internet. This approach has broad applicability to other diseases typified by recurrent attacks. 相似文献
33.
Virological efficacy with first‐line antiretroviral treatment in India: predictors of viral failure and evidence of viral resuppression
下载免费PDF全文
![点击此处可从《Tropical medicine & international health : TM & IH》网站下载免费的PDF全文](/ch/ext_images/free.gif)
34.
35.
Seoyoung C. Kim Tuhina Neogi Eun Ha Kang Jun Liu Rishi J. Desai MaryAnn Zhang Daniel H. Solomon 《Journal of the American College of Cardiology》2018,71(9):994-1004
Background
Patients with gout are at an increased risk of cardiovascular (CV) disease including myocardial infarction (MI), stroke, and heart failure (HF).Objectives
The authors conducted a cohort study to examine comparative CV safety of the 2 gout treatments—probenecid and allopurinol—in patients with gout.Methods
Among gout patients ≥65 years of age and enrolled in Medicare (2008 to 2013), those who initiated probenecid or allopurinol were identified. The primary outcome was a composite CV endpoint of hospitalization for MI or stroke. MI, stroke, coronary revascularization, HF, and mortality were assessed separately as secondary outcomes. The authors estimated the incidence rate and hazard ratio of the primary and secondary outcomes in the 1:3 propensity score–matched cohort of probenecid and allopurinol initiators.Results
A total of 9,722 probenecid initiators propensity score–matched to 29,166 allopurinol initiators with mean age of 76 ± 7 years, and 54% males were included. The incidence rate of the primary composite endpoint of MI or stroke per 100 person-years was 2.36 in probenecid and 2.83 in allopurinol initiators with a hazard ratio of 0.80 (95% confidence interval: 0.69 to 0.93). In the secondary analyses, probenecid was associated with a decreased risk of MI, stroke, HF exacerbation, and mortality versus allopurinol. These results were consistent in the subgroup analyses of patients without baseline CV disease or those without baseline chronic kidney disease.Conclusions
In this large cohort of 38,888 elderly gout patients, treatment with probenecid appears to be associated with a modestly decreased risk of CV events including MI, stroke, and HF exacerbation compared with allopurinol. 相似文献36.
37.
Sangmee Bae Manjit K. Singh Tuhina Neogi Joan Merill Susan Lee Shraddha Prakash Marian Kaldas Maneesh Gogia Will Taylor Sanford Kaplan Danielle Jones Steven A. Yarows Blake Roessler Charles King Gerald Levy Daniel E. Furst Mark Robbins Neil Wenger Robert Terkeltaub 《Arthritis care & research》2012,64(10):1431-1446
38.
39.
Daniel K. White Catrine Tudor‐Locke David T. Felson K. Douglas Gross Jingbo Niu Michael Nevitt Cora E. Lewis James Torner Tuhina Neogi 《Arthritis \u0026amp; Rheumatology》2013,65(1):139-147
Objective
Knee osteoarthritis (OA) and pain are assumed to be barriers to meeting physical activity guidelines, but this has not been formally evaluated. The purpose of this study was to determine the proportions of people with and those without knee OA and knee pain who meet recommended physical activity levels through walking.Methods
We performed a cross‐sectional analysis of community‐dwelling adults from the Multicenter Osteoarthritis Study who had or who were at high risk of knee OA. Participants wore a StepWatch activity monitor to record steps per day for 7 days. The proportion of participants who met the recommended physical activity levels was defined as those accumulating ≥150 minutes per week at ≥100 steps per minute in bouts lasting ≥10 minutes. These proportions were also determined for those with and those without knee OA, as classified by radiography and by severity of knee pain.Results
Of the 1,788 study participants (mean ± SD age 67.2 ± 7.7 years, mean ± SD body mass index 30.7 ± 6.0 kg/m2, 60% women), lower overall percentages of participants with radiographic knee OA and knee pain met recommended physical activity levels. However, these differences were not statistically significant between those with and those without knee OA; 7.3% and 10.1% of men (P = 0.34) and 6.3% and 7.8% of women (P = 0.51), respectively, met recommended physical activity levels. Similarly, for those with moderate/severe knee pain and those with no knee pain, 12.9% and 10.9% of men (P = 0.74) and 6.7% and 11.0% of women (P = 0.40), respectively, met recommended physical activity levels.Conclusion
Disease and pain have little impact on achieving recommended physical activity levels among people with or at high risk of knee OA.40.